Next Article in Journal
Signaling Circuits and Regulation of Immune Suppression by Ovarian Tumor-Associated Macrophages
Previous Article in Journal
Integrating Immune Checkpoint Blockade with Anti-Neo/Mutated Antigens Reactivity to Increase the Clinical Outcome of Immunotherapy
Previous Article in Special Issue
Vaccinia Virus LC16m8∆ as a Vaccine Vector for Clinical Applications
Article Menu

Export Article

Open AccessReview
Vaccines 2015, 3(2), 429-447;

Emerging Vaccine Technologies

The Children's Hospital of Philadelphia Research Institute, Philadelphia, PA 19104, USA
Author to whom correspondence should be addressed.
Academic Editor: Diane M. Harper
Received: 24 December 2014 / Revised: 5 May 2015 / Accepted: 18 May 2015 / Published: 26 May 2015
(This article belongs to the Special Issue Vaccine Vector)
Full-Text   |   PDF [319 KB, uploaded 26 May 2015]


Vaccination has proven to be an invaluable means of preventing infectious diseases by reducing both incidence of disease and mortality. However, vaccines have not been effectively developed for many diseases including HIV-1, hepatitis C virus (HCV), tuberculosis and malaria, among others. The emergence of new technologies with a growing understanding of host-pathogen interactions and immunity may lead to efficacious vaccines against pathogens, previously thought impossible. View Full-Text
Keywords: vaccine; reverse vaccinology; structural vaccinology; epitope-scaffold; immunoprophylaxis vaccine; reverse vaccinology; structural vaccinology; epitope-scaffold; immunoprophylaxis
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Loomis, R.J.; Johnson, P.R. Emerging Vaccine Technologies. Vaccines 2015, 3, 429-447.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top